Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.03−0.62 (-5.82%)
Close on Nov 13, 2026Market cap $259.18MP/E –Yield –
Faeth Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Faeth Therapeutics
Faeth Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?